BUZZ-Waystar rises after brokerage upgrades to 'strong buy'

Reuters11-22

** Shares of healthcare payments firm Waystar up 1.5% at $31.60

** Raymond James upgrades stock rating to "strong buy" from "outperform", maintains PT of $40

** The current valuation does not reflect the potential durability of double-digit growth amid broader secular shifts in healthcare to more modern technology - brokerage

** Growing healthcare complexity will only compound the regulatory and administrative burden on providers, which we think will disproportionally benefit vertical SaaS players with a suite sale - Raymond James

** Avg. rating of 10 brokerages for the stock is a "buy"; the median PT is $36, according to data compiled by LSEG

** As of last close, shares up 44.8% from WAY's June IPO price of $21.50

(Reporting by Sukriti Gupta in Bengaluru)

((Sukriti.Gupta@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2485267114?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-11-22 23:35","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2485267114","market":"us","top_or_hot":-1,"title":"BUZZ-Waystar rises after brokerage upgrades to 'strong buy'","media":"Reuters","content":"<html><body><p>** Shares of healthcare payments firm Waystar    up 1.5% at $31.60 </p><p>   ** Raymond James upgrades stock rating to \"strong buy\" from \"outperform\", maintains PT of $40</p><p>       ** The current valuation does not reflect the potential durability of double-digit growth amid broader secular shifts in healthcare to more modern technology - brokerage</p><p>   ** Growing healthcare complexity will only compound the regulatory and administrative burden on providers, which we think will disproportionally benefit vertical SaaS players with a suite sale - Raymond James</p><p>       ** Avg. rating of 10 brokerages for the stock is a \"buy\"; the median PT is $36, according to data compiled by LSEG</p><p>   ** As of last close, shares up 44.8% from WAY's June IPO price of $21.50 </p><p> (Reporting by Sukriti Gupta in Bengaluru)</p><p>((Sukriti.Gupta@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BUZZ-Waystar rises after brokerage upgrades to 'strong buy'</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBUZZ-Waystar rises after brokerage upgrades to 'strong buy'\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-22 23:35 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>** Shares of healthcare payments firm Waystar    up 1.5% at $31.60    ** Raymond James upgrades stock rating to \"strong buy\" from \"outperform\", maintains PT of $40       ** The current valuation does ...</p>\n\n<a href=\"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"WAY","symbol_name":"Waystar Holding Corp.","start_time":0,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2485267114","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2485267114","pubTimestamp":1732289740,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"** Shares of healthcare payments firm Waystar    up 1.5% at $31.60    ** Raymond James upgrades stock rating to \"strong buy\" from \"outperform\", maintains PT of $40       ** The current valuation does not reflect the potential durability of double-digit growth amid broader secular shifts in healthcare to more modern technology - brokerage   ** Growing healthcare complexity will only compound the regulatory and administrative burden on providers, which we think will disproportionally benefit vertical SaaS players with a suite sale - Raymond James       ** Avg. rating of 10 brokerages for the stock is a \"buy\"; the median PT is $36, according to data compiled by LSEG   ** As of last close, shares up 44.8% from WAY's June IPO price of $21.50  ","collect":0,"end_time":0,"defaultTopTitle":"","property":["rate"],"viewcount":null,"language":"en","relate_stocks":{"WAY":"Waystar Holding Corp."},"translate_title":"券商将BUZZ-Waystar评级上调至“强力买入”后股价上涨","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"WAY":0.9},"content_text":"** Shares of healthcare payments firm Waystar    up 1.5% at $31.60    ** Raymond James upgrades stock rating to \"strong buy\" from \"outperform\", maintains PT of $40       ** The current valuation does not reflect the potential durability of double-digit growth amid broader secular shifts in healthcare to more modern technology - brokerage   ** Growing healthcare complexity will only compound the regulatory and administrative burden on providers, which we think will disproportionally benefit vertical SaaS players with a suite sale - Raymond James       ** Avg. rating of 10 brokerages for the stock is a \"buy\"; the median PT is $36, according to data compiled by LSEG   ** As of last close, shares up 44.8% from WAY's June IPO price of $21.50  (Reporting by Sukriti Gupta in Bengaluru)((Sukriti.Gupta@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2485267114"}